Human Transitional B Cells: Homeostasis, Function, and Impact of BCDT

人类移行 B 细胞:稳态、功能和 BCDT 的影响

基本信息

  • 批准号:
    8528452
  • 负责人:
  • 金额:
    $ 32.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-01 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY (See instructions): B cells play a critical role in the pathogenesis of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). A major focus of Project I is to define the bone marrow developmental cues and peripheral turnover of transitional B cells and how cytokine milieu, which may be perturbed in systemic autoimmunity, regulates this process. It is hypothesized that autoimmune disease is as.sociated with dysregulation of transitional B cell homeostasis during B cell development with alterations in the numbers of transitional B cells emerging from the bone marrow (BM), the inicroenvironmenlal signals that modulate this process (IFN, TNF), and the signaling threshold for progression to the mature compartinent (BAFF). On the other hand, we have found that SLE patients with a prominent expansion of circulating transitional cells after B cell depletion therapy (BCDT) enter long-term clinical remission, whereas both SLE and RA patients with more rapid memory reconstitution experience earlier relapse of disease. The focus of this proposal is to understand early B cell homeostasis and the factors that regulate B cell reconstitution after BCDT in SLE and RA through the following specific aims which will define: 1. the perturbations in homeostasis of human transitional B cells in autoimmune di.sease; 2. the factors which regulate the balance of reconstitution of distinct B cell subsets after BCDT; and 3. the reciprocal regulation of transitional B cells and regulatory T cells and how this is altered in autoimmune disease and after BCDT. Specifically, we will define the dynamics of B cell development in humans using B cell depletion as a tool and multi-parameter flow cytometry. The lifespan and turnover of transitional B cells will be assessed by heavy water labeling, replication history, cell cycle, and delineation of survival and .selection. The effects of cytokine milieu on new BM B cell lyinphopoeisis will be examined. This project will explore the hypothesis that the outcome of BCDT rellects the balance between protective (regulatory, anti-inflammatory) and effector (prointlammatoiy) B cells and their corresponding cytokines. Transitional B cell functions to delineate include the production of anti-intlammatory cytokines such as IL-10 and TGFB and support of regulatory T cell (Treg) development. We will define whether human B cell subsets differentially support Treg expansion or are differentially susceptible to Treg suppression, if this function changes in autoimmune settings, and how these abnormalities are modified by BCDT. Elucidation of the homeostatic regulation of human transitional B cells will represent a major advance in human B cell biology. The research proposed will also help us understand how B cell development is dysregulated in autoimmune disease and how depletion induces improvement and, in some cases, long-lasting disea.se remission.
项目总结(见说明): B细胞在系统性红斑狼疮(SLE)和类风湿关节炎(RA)的发病机制中起重要作用。一个 项目I的主要焦点是确定骨髓发育线索和移行B细胞的外周更新 以及在系统自身免疫中可能受到干扰的细胞因子环境是如何调节这一过程的。这是假设的 自身免疫性疾病与B细胞发育过程中过渡性B细胞平衡失调有关 随着从骨髓(BM)中涌出的移行B细胞数量的变化,内微环境 调节这一过程的信号(干扰素、肿瘤坏死因子),以及进入成熟室的信号阈值 (Baff)。另一方面,我们发现SLE患者具有明显的循环过渡性扩张 B细胞去除治疗(BCDT)后的细胞进入长期临床缓解,而SLE和RA患者 记忆重建越快,疾病复发的时间越早。这项建议的重点是及早了解 系统性红斑狼疮和类风湿关节炎患者BCDT后B细胞稳态及调节B细胞重建的因素 具体目标将定义:1.自身免疫中人类过渡性B细胞的动态平衡紊乱 BCDT后不同B细胞亚群重建平衡的调节因素; 过渡性B细胞和调节性T细胞的相互调节以及这种调节在自身免疫性疾病和 在BCDT之后。具体地说,我们将使用B细胞耗尽作为工具来定义人类B细胞发育的动力学 多参数流式细胞术。过渡性B细胞的寿命和周转率将通过重水进行评估 标记,复制历史,细胞周期,以及生存和选择的描绘。细胞因子环境对新生血管生成的影响 将检查骨髓B细胞的造血功能。本项目将探索BCDT的结果反映 保护性(调节性、抗炎性)和效应性(原板层)B细胞之间的平衡及其 相应的细胞因子。过渡性B细胞功能的描绘包括抗炎的产生 IL-10和TGFb等细胞因子与调节性T细胞(Treg)发育的支持。我们将定义人类是否 B细胞亚群不同地支持Treg扩展或不同地易受Treg抑制,如果此函数 自身免疫设置的变化,以及BCDT如何改变这些异常。关于动态平衡的阐明 人类过渡性B细胞的调控将代表着人类B细胞生物学的重大进展。这项研究建议 也将帮助我们理解自身免疫性疾病中B细胞发育是如何失调的,以及耗竭是如何导致的 病情改善,在某些情况下,可长期缓解疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Howitt Anolik其他文献

Jennifer Howitt Anolik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Howitt Anolik', 18)}}的其他基金

Pain and synovial pathotypes in AMP AIM
AMP AIM 中的疼痛和滑膜病理类型
  • 批准号:
    10856445
  • 财政年份:
    2022
  • 资助金额:
    $ 32.86万
  • 项目类别:
AIM-for-RA
RA 的 AIM
  • 批准号:
    10451387
  • 财政年份:
    2022
  • 资助金额:
    $ 32.86万
  • 项目类别:
AIM-for-RA
RA 的 AIM
  • 批准号:
    10595666
  • 财政年份:
    2022
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    8851812
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    9318123
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    8932656
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    10200988
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    10166379
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    9913036
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:
Cellular Dynamics at the Synovium-Bone interface in RA
RA 滑膜-骨界面的细胞动力学
  • 批准号:
    9276491
  • 财政年份:
    2014
  • 资助金额:
    $ 32.86万
  • 项目类别:

相似海外基金

Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
  • 批准号:
    23K07659
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
  • 批准号:
    23K19490
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
  • 批准号:
    10697567
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
  • 批准号:
    10727765
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
  • 批准号:
    23K08467
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
  • 批准号:
    493138
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
  • 批准号:
    2223225
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
  • 批准号:
    10651054
  • 财政年份:
    2023
  • 资助金额:
    $ 32.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了